Early prediction of autoimmune (type 1) diabetes.
Open accessThe DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Abstract
Underlying type 1 diabetes is a genetic aetiology dominated by the influence of specific HLA haplotypes involving primarily the class II DR-DQ region. In genetically predisposed children with the DR4-DQ8 haplotype, exogenous factors, yet to be identified, are thought to trigger an autoimmune reaction against insulin, signalled by insulin autoantibodies as the first autoantibody to appear. In children with the DR3-DQ2 haplotype, the triggering reaction is primarily against GAD signalled by GAD autoantibodies (GADA) as the first-appearing autoantibody. The incidence rate of insulin autoantibodies as the first-appearing autoantibody peaks during the first years of life and declines thereafter. The incidence rate of GADA as the first-appearing autoantibody peaks later but does not decline. The first autoantibody may variably be followed, in an apparently non-HLA-associated pathogenesis, by a second, third or fourth autoantibody. Although not all persons with a single type of autoantibody progress to diabetes, the presence of multiple autoantibodies seems invariably to be followed by loss of functional beta cell mass and eventually by dysglycaemia and symptoms. Infiltration of mononuclear cells in and around the islets appears to be a late phenomenon appearing in the multiple-autoantibody-positive with dysglycaemia. As our understanding of the aetiology and pathogenesis of type 1 diabetes advances, the improved capability for early prediction should guide new strategies for the prevention of type 1 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Proposed staging of type 1 diabetes. The aetiology is represented by a variable genetic and environmental risk. The pathogenesis is represented by three stages. In stage 1, beta cell autoantibodies are persistent, normoglycaemia prevails and there are no symptoms. During stage 2, the number of beta cell autoantibodies may affect the pathogenesis to induce dysglycaemia but there are still no diabetes symptoms. In stage 3, beta cell autoantibodies are still prevalent (some of them may have been lost) and there are symptoms of diabetes. The staging of type 1 diabetes pathogenesis was proposed by Insel et al [1] and the figure is adapted with permission from Insel et al [1]. © 2015 The American Diabetes Association](https://figures.cochat.ai/paper-figures/ec2c0c7eba0c42db9615a6352c9e3db7/early-prediction-of-autoimmune-type-1-diabetes-figure-1.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although the prevalence of several autoantibodies associated with T1DM tends to decrease with increasing age at diagnosis61, GADA remains the dominant autoantibody in adult-onset T1DM regardless of ethnicity62–64.”
From The epidemiology of type 1 diabetes mellitus in older adults (2025) · cites this paper as [61]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Approximately twice as many women are diagnosed with gestational diabetes using the IADPSG criteria compared with the Carpenter-Coustan criteria.6”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [6]
Experimental — accuracy not yet measuredThe check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The risk factors for progression to type 2 diabetes include maternal age, prepartum and postpartum BMI, family history of type 2 diabetes, receipt of insulin for gestational diabetes, and fasting glucose level during pregnancy.6,[24][25][26]”
From Association of Gestational Diabetes With Maternal Disorders of Glucose Metabolism and Childhood Adiposity (2018) · cites this paper as [6]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Ueda, H., Howson, J. M. M., Esposito, L., Heward, J., Snook, Chamberlain, G., Rainbow, D. B., Hunter, K. M. D., Smith, A. N., Di Genova, G., et al. (2003) · Nature · doi:10.1038/nature01621 · Cited by 2,175 · cited 1×
“Many of these genes are implicated in immune system regulation in particular and beta cell function less often [38, 39].”
BackgroundSeroconversion to multiple islet autoantibodies and risk of progression to diabetes in children
Ziegler, A. G., Rewers, M., Simell, O., Simell, T., Lempainen, J., Steck, A., Winkler, C., Ilonen, J., Veijola, R., Knip, M., et al. (2013) · JAMA · doi:10.1001/jama.2013.6285 · Cited by 1,312
Insel, R. A., Dunne, J. L., Atkinson, M. A., Chiang, J. L., Dabelea, D., Gottlieb, P. A., Greenbaum, C. J., Herold, K. C., Krischer, J. P., Lernmark, Å., et al. (2015) · Diabetes Care · doi:10.2337/dc15-1419 · Cited by 1,216 · cited 1×
“The staging of type 1 diabetes pathogenesis was proposed by Insel et al [1] and the figure is adapted with permission from Insel et al [1].”
MethodSelf-citationIncidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group
Karvonen, M., Viik-Kajander, M., Moltchanova, E., Libman, I., LaPorte, R., & Tuomilehto, J. (2000) · Diabetes Care · doi:10.2337/diacare.23.10.1516 · Cited by 1,072
Type 1 Diabetes: Etiology, Immunology, and Therapeutic Strategies
Van Belle, T. L., Coppieters, K. T., & Von Herrath, M. G. (2011) · Physiological Reviews · doi:10.1152/physrev.00003.2010 · Cited by 1,022 · cited 1×
“Beta cell autoantibodies, long regarded as merely markers of the autoimmune process, may contribute through B cells presenting antigens to CD4 and CD8 T cells [79].”
BackgroundThe role of inflammation in insulitis and β-cell loss in type 1 diabetes
Eizirik, D. L., Colli, M. L., & Ortis, F. (2009) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2009.21 · Cited by 1,011 · cited 1×
“Although B and Tcell activity is a known key driver of beta cell destruction, the role of the innate immune system in type 1 diabetes is also recognised [86].”
BackgroundType 1 Diabetes Through the Life Span: A Position Statement of the American Diabetes Association
Chiang, J. L., Kirkman, M. S., Laffel, L. M. B., Peters, A. L., & Authors, O. B. O. T. T. 1. D. S. (2014) · Diabetes Care · doi:10.2337/dc14-1140 · Cited by 965
β-Cell death during progression to diabetes
Mathis, D., Vence, L., & Benoist, C. (2001) · Nature · doi:10.1038/414792a · Cited by 884
HLA DR-DQ Haplotypes and Genotypes and Type 1 Diabetes Risk
Erlich, H., Valdes, A. M., Noble, J., Carlson, J. A., Varney, M., Concannon, P., Mychaleckyj, J. C., Todd, J. A., Bonella, P., Fear, A. L., et al. (2008) · Diabetes · doi:10.2337/db07-1331 · Cited by 790 · cited 1×
“5% of individuals with and without type 1 diabetes, respectively [25].”
BackgroundMajor Histocompatibility Complex Genomics and Human Disease
Trowsdale, J., & Knight, J. C. (2013) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev-genom-091212-153455 · Cited by 759 · cited 2×
“The HLA class III region is genetically dense and codes for several proteins important to the immune system, such as complement factors and TNF-α [12].”
BackgroundSteffes, M. W., Sibley, S., Jackson, M., & Thomas, W. (2003) · Diabetes Care · doi:10.2337/diacare.26.3.832 · Cited by 695
Environmental risk factors for type 1 diabetes
Rewers, M., & Ludvigsson, J. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30507-4 · Cited by 676 · cited 4×
“However, clinical trials have so far been unsuccessful [45].”
BackgroundResultInfluentialZiegler, A. G., Hummel, M., Schenker, M., & Bonifacio, E. (1999) · Diabetes · doi:10.2337/diabetes.48.3.460 · Cited by 645
Pervasive Sharing of Genetic Effects in Autoimmune Disease
Cotsapas, C., Voight, B. F., Rossin, E., Lage, K., Neale, B. M., Wallace, C., Abecasis, G. R., Barrett, J. C., Behrens, T., Cho, J., et al. (2011) · PLoS Genetics · doi:10.1371/journal.pgen.1002254 · Cited by 606 · cited 1×
“Some genetic susceptibility variants are shared with other autoimmune disorders, including coeliac disease and Crohn’s disease [41].”
BackgroundGenetic risk factors for type 1 diabetes
Pociot, F., & Lernmark, Å. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30582-7 · Cited by 553
Self-citationNoble, J. A., Valdes, A. M., Cook, M., Klitz, W., Thomson, G., & Erlich, H. A. (1996) · PubMed · Cited by 551
(1998) · Annals of Internal Medicine · doi:10.7326/0003-4819-128-7-199804010-00001 · Cited by 546
Genetic insights into common pathways and complex relationships among immune-mediated diseases
Parkes, M., Cortes, A., van Heel, D. A., & Brown, M. A. (2013) · Nature Reviews Genetics · doi:10.1038/nrg3502 · Cited by 526 · cited 1×
“Known shared loci between type 1 diabetes and rheumatoid arthritis, psoriasis and coeliac disease are concordant, whereas more than half of the SNPs influencing the risk of type 1 diabetes are discordant with genes influencing risk of inflammatory bowel disease and ankylosing spondylitis [42].”
BackgroundMeier, J. J., Bhushan, A., Butler, A. E., Rizza, R. A., & Butler, P. C. (2005) · Diabetologia · doi:10.1007/s00125-005-1949-2 · Cited by 493 · cited 1×
“This is consistent with histological evidence that functional beta cells can be found in long-standing type 1 diabetes [105].”
ResultImmune cell crosstalk in type 1 diabetes
Lehuen, A., Diana, J., Zaccone, P., & Cooke, A. (2010) · Nature Reviews Immunology · doi:10.1038/nri2787 · Cited by 476 · cited 1×
“It is thought that cytotoxic T cells, helper T cells, natural killer cells and macrophages contribute to the actual destruction of beta cells [80].”
BackgroundOrešič, M., Simell, S., Sysi-Aho, M., Näntö-Salonen, K., Seppänen-Laakso, T., Parikka, V., Katajamaa, M., Hekkala, A., Mattila, I., Keskinen, P., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081800 · Cited by 449 · cited 2×
“velopment of beta cell autoimmunity [111].”
Backgroundthe TEDDY Study Group, Krischer, J. P., Lynch, K. F., Schatz, D. A., Ilonen, J., Lernmark, Å., Hagopian, W. A., Rewers, M. J., She, J.-X., Simell, O. G., et al. (2015) · Diabetologia · doi:10.1007/s00125-015-3514-y · Cited by 444 · cited 18×
“In adults, GADA appear more frequently than other islet autoantibodies and symptoms following progressive insulin deficiency may appear more gradually [125, 126].”
BackgroundInfluentialSelf-citationThe role of the intestinal microbiota in type 1 diabetes mellitus
Knip, M., & Siljander, H. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.218 · Cited by 434 · cited 2×
“The current evidence thus suggests that the microbiome may reflect the development of clinical disease in persons with demonstrable autoimmunity, but not the initiation of autoimmunity itself [114].”
BackgroundHyöty, H., Hiltunen, M., Knip, M., Laakkonen, M., Vähäsalo, P., Karjalainen, J., Koskela, P., Roivainen, M., Leinikki, P., Hovi, T., et al. (1995) · Diabetes · doi:10.2337/diab.44.6.652 · Cited by 419
Genetic Liability of Type 1 Diabetes and the Onset Age Among 22,650 Young Finnish Twin Pairs
Hyttinen, V., Kaprio, J., Kinnunen, L., Koskenvuo, M., & Tuomilehto, J. (2003) · Diabetes · doi:10.2337/diabetes.52.4.1052 · Cited by 394 · cited 1×
“Only about half of monozygotic twins are concordant for type 1 diabetes [8], suggesting environmental and/or epigenetic influences [9].”
BackgroundBingley, P. J., Christie, M. R., Bonifacio, E., Bonfanti, R., Shattock, M., Fonte, M.-T., Bottazzo, G.-F., & Gale, E. A. M. (1994) · Diabetes · doi:10.2337/diab.43.11.1304 · Cited by 389
Insulitis and β-Cell Mass in the Natural History of Type 1 Diabetes
Campbell-Thompson, M., Fu, A., Kaddis, J. S., Wasserfall, C., Schatz, D. A., Pugliese, A., & Atkinson, M. A. (2016) · Diabetes · doi:10.2337/db15-0779 · Cited by 356 · cited 3×
“Insulitis may persist for years after diabetes onset but correlates negatively with duration of diabetes [78].”
BackgroundAdult-Onset Autoimmune Diabetes in Europe Is Prevalent With a Broad Clinical Phenotype
Hawa, M. I., Kolb, H., Schloot, N., Beyan, H., Paschou, S. A., Buzzetti, R., Mauricio, D., De Leiva, A., Yderstraede, K., Beck-Neilsen, H., et al. (2013) · Diabetes Care · doi:10.2337/dc12-0931 · Cited by 339 · cited 1×
“In adults, GADA appear more frequently than other islet autoantibodies and symptoms following progressive insulin deficiency may appear more gradually [125, 126].”
BackgroundNoble, J. A., & Erlich, H. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007732 · Cited by 335
Genetics of Type 1 Diabetes: What's Next?
Pociot, F., Akolkar, B., Concannon, P., Erlich, H. A., Julier, C., Morahan, G., Nierras, C. R., Todd, J. A., Rich, S. S., & Nerup, J. (2010) · Diabetes · doi:10.2337/db10-0076 · Cited by 300
Association of Early Exposure of Probiotics and Islet Autoimmunity in the TEDDY Study
Uusitalo, U., Liu, X., Yang, J., Aronsson, C. A., Hummel, S., Butterworth, M., Lernmark, Å., Rewers, M., Hagopian, W., She, J.-X., et al. (2016) · JAMA Pediatrics · doi:10.1001/jamapediatrics.2015.2757 · Cited by 292 · cited 1×
“one as-yet-unconfirmed report administration of probiotics during the first 27 days of life reduced the risk for a firstappearing beta cell autoantibody in children with the HLA-DQ2/8 genotype [59].”
BackgroundSelf-citationClinical Applications of Diabetes Antibody Testing
Bingley, P. J. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1365 · Cited by 278
HLA Class I and Genetic Susceptibility to Type 1 Diabetes
Noble, J. A., Valdes, A. M., Varney, M. D., Carlson, J. A., Moonsamy, P., Fear, A. L., Lane, J. A., Lavant, E., Rappner, R., Louey, A., et al. (2010) · Diabetes · doi:10.2337/db10-0699 · Cited by 254
Relationship between β‐cell mass and diabetes onset
Matveyenko, A. V., & Butler, P. C. (2008) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2008.00939.x · Cited by 247
Lambert, A. P., Gillespie, K. M., Thomson, G., Cordell, H. J., Todd, J. A., Gale, E. A. M., & Bingley, P. J. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032084 · Cited by 241 · cited 1×
“Children with the high-risk DRB1*03:01-DQA1*05:01-DQB1*02:01/ DRB1*04:01-DQA1*03:01-DQB1*03:02 genotype have a 5% incidence of diabetes by 15 years of age [26].”
BackgroundThirty Years of Prospective Nationwide Incidence of Childhood Type 1 Diabetes
Berhan, Y., Waernbaum, I., Lind, T., Möllsten, A., Dahlquist, G., & for the Swedish Childhood Diabetes Study Group* (2011) · Diabetes · doi:10.2337/db10-0813 · Cited by 237
Genetic effects on age-dependent onset and islet cell autoantibody markers in type 1 diabetes
Graham, J., Hagopian, W. A., Kockum, I., Li, L. S., Sanjeevi, C. B., Lowe, R. M., Schaefer, J. B., Zarghami, M., Day, H. L., Landin-Olsson, M., et al. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1346 · Cited by 230
The epidemiology of diabetes in Swedish children 0?14 years ? a six-year prospective study
Dahlquist, G., Blom, L., Holmgren, G., H�ggl�f, B., Larsson, Y., Sterky, G., & Wall, S. (1985) · Diabetologia · doi:10.1007/bf00291068 · Cited by 214 · cited 1×
“The disease clusters in some families, yet only about 13% of patients have a first-degree relative with type 1 diabetes [5].”
BackgroundPatterns of β-Cell Autoantibody Appearance and Genetic Associations During the First Years of Life
Ilonen, J., Hammais, A., Laine, A.-P., Lempainen, J., Vaarala, O., Veijola, R., Simell, O., & Knip, M. (2013) · Diabetes · doi:10.2337/db13-0300 · Cited by 205 · cited 3×
“Once a first beta cell autoantibody has appeared, the appearance of a second does not seem to be associated with HLA [3].”
BackgroundScreening for Insulitis in Adult Autoantibody-Positive Organ Donors
In't Veld, P., Lievens, D., De Grijse, J., Ling, Z., Van der Auwera, B., Pipeleers-Marichal, M., Gorus, F., & Pipeleers, D. (2007) · Diabetes · doi:10.2337/db07-0416 · Cited by 198
Bonifacio, E., Ziegler, A.-G., Klingensmith, G., Schober, E., Bingley, P. J., Rottenkolber, M., Theil, A., Eugster, A., Puff, R., Peplow, C., et al. (2015) · JAMA · doi:10.1001/jama.2015.2928 · Cited by 196
Steck, A. K., Johnson, K., Barriga, K. J., Miao, D., Yu, L., Hutton, J. C., Eisenbarth, G. S., & Rewers, M. J. (2011) · Diabetes Care · doi:10.2337/dc10-2088 · Cited by 195 · cited 1×
“single tomultiple beta cell autoantibodies and lower IAA titres may predict a delayed clinical onset [66, 67].”
BackgroundCan we slow the rising incidence of childhood-onset autoimmune diabetes? The overload hypothesis
Dahlquist, G. (2006) · Diabetologia · doi:10.1007/s00125-005-0076-4 · Cited by 194 · cited 1×
“clinical onset of type 1 diabetes in persons with beta cell autoimmunity [60].”
BackgroundPredicting Type 1 Diabetes Using Biomarkers
Bonifacio, E. (2015) · Diabetes Care · doi:10.2337/dc15-0101 · Cited by 191 · cited 1×
“terns of antibody titres may vary without a clear prognostic significance [74].”
BackgroundThomson, G., Valdes, A. M., Noble, J. A., Kockum, I., Grote, M. N., Najman, J., Erlich, H. A., Cucca, F., Pugliese, A., Steenkiste, A., et al. (2007) · Tissue Antigens · doi:10.1111/j.1399-0039.2007.00867.x · Cited by 189
Self-citationKallionpää, H., Elo, L. L., Laajala, E., Mykkänen, J., Ricaño-Ponce, I., Vaarma, M., Laajala, T. D., Hyöty, H., Ilonen, J., Veijola, R., et al. (2014) · Diabetes · doi:10.2337/db13-1775 · Cited by 188 · cited 1×
“In the latter group, the gene expression signature preceded the appearance of autoantibodies [108, 109].”
BackgroundSteck, A. K., Vehik, K., Bonifacio, E., Lernmark, A., Ziegler, A.-G., Hagopian, W. A., She, J., Simell, O., Akolkar, B., Krischer, J., et al. (2015) · Diabetes Care · doi:10.2337/dc14-2426 · Cited by 185 · cited 1×
“followed the first islet autoantibody [69].”
Cell Death Mediators in Autoimmune Diabetes—No Shortage of Suspects
Benoist, C., & Mathis, D. (1997) · Cell · doi:10.1016/s0092-8674(00)80174-9 · Cited by 174 · cited 1×
“While several modes of action have been proposed in the mouse [81, 82], the pathogenic pathway is less understood in humans.”
BackgroundHydrolyzed Infant Formula and Early β-Cell Autoimmunity: A Randomized Clinical Trial
Knip, M., Åkerblom, H. K., Becker, D., Dosch, H.-M., Dupre, J., Fraser, W., Howard, N., Ilonen, J., Krischer, J. P., Kordonouri, O., et al. (2014) · JAMA · doi:10.1001/jama.2014.5610 · Cited by 167 · cited 1×
“Hydrolysed infant formula did not prevent the appearance of beta cell autoantibodies [57].”
BackgroundRole of Type 1 Diabetes–Associated SNPs on Risk of Autoantibody Positivity in the TEDDY Study
Törn, C., Hadley, D., Lee, H.-S., Hagopian, W., Lernmark, Å., Simell, O., Rewers, M., Ziegler, A., Schatz, D., Akolkar, B., et al. (2015) · Diabetes · doi:10.2337/db14-1497 · Cited by 151
Self-citationGenetic Association Between a Lymphoid Tyrosine Phosphatase (PTPN22) and Type 1 Diabetes
Zheng, W., & She, J.-X. (2005) · Diabetes · doi:10.2337/diabetes.54.3.906 · Cited by 143
Nguyen, C., Varney, M. D., Harrison, L. C., & Morahan, G. (2013) · Diabetes · doi:10.2337/db12-1398 · Cited by 141 · cited 1×
“DRB1*04 combined with DQA1*03-DQB1*03:01 does not [14, 15].”
β Cell death and dysfunction during type 1 diabetes development in at-risk individuals
Herold, K. C., Usmani-Brown, S., Ghazi, T., Lebastchi, J., Beam, C. A., Bellin, M. D., Ledizet, M., Sosenko, J. M., Krischer, J. P., & Palmer, J. P. (2015) · Journal of Clinical Investigation · doi:10.1172/jci78142 · Cited by 140 · cited 2×
“1 of type 1 diabetes, fluctuations of insulin secretion may be detected, probably due to reversible beta cell stressors rather than beta cell death per se [89].”
BackgroundDahlquist, G. G., Frisk, G., Ivarsson, S. A., Svanberg, L., Forsgren, M., & Diderholm, H. (1995) · Diabetologia · doi:10.1007/bf00401772 · Cited by 140 · cited 1×
“Coxsackie infection during pregnancy may induce beta cell autoimmunity in the mother [53] and may increase the risk for type 1 diabetes in the offspring [54, 55].”
BackgroundPrediction of Type 1 Diabetes in the General Population
Knip, M., Korhonen, S., Kulmala, P., Veijola, R., Reunanen, A., Raitakari, O. T., Viikari, J., & Åkerblom, H. K. (2010) · Diabetes Care · doi:10.2337/dc09-1040 · Cited by 140 · cited 1×
“Up to 60% of persons positive for a single autoantibody may revert to seronegativity [73] and pat-”
BackgroundProgression to Diabetes in Relatives of Type 1 Diabetic Patients: Mechanisms and Mode of Onset
Ferrannini, E., Mari, A., Nofrate, V., Sosenko, J. M., Skyler, J. S., & for the DPT-1 Study Group (2010) · Diabetes · doi:10.2337/db09-1378 · Cited by 140
Oram, R. A., McDonald, T. J., Shields, B. M., Hudson, M. M., Shepherd, M. H., Hammersley, S., Pearson, E. R., Hattersley, A. T., & on behalf of the UNITED Team (2015) · Diabetes Care · doi:10.2337/dc14-0871 · Cited by 133 · cited 1×
“Recent studies employing highly sensitive C-peptide assays suggest that individuals with long-term type 1 diabetes secrete residual amounts of insulin [104].”
BackgroundPugliese, A., Yang, M., Kusmarteva, I., Heiple, T., Vendrame, F., Wasserfall, C., Rowe, P., Moraski, J. M., Ball, S., Jebson, L., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12097 · Cited by 132
Bergholdt, R., Brorsson, C., Palleja, A., Berchtold, L. A., Fløyel, T., Bang-Berthelsen, C. H., Frederiksen, K. S., Jensen, L. J., Størling, J., & Pociot, F. (2012) · Diabetes · doi:10.2337/db11-1263 · Cited by 125
Klinke, D. J. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001374 · Cited by 124 · cited 1×
“Indeed, those who are older at onset tend to have more beta cells than young children and loss of 40% of beta cells can be sufficient to induce symptoms in a 20-year-old person [98].”
BackgroundNoninvasive mapping of pancreatic inflammation in recent-onset type-1 diabetes patients
Gaglia, J. L., Harisinghani, M., Aganj, I., Wojtkiewicz, G. R., Hedgire, S., Benoist, C., Mathis, D., & Weissleder, R. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1424993112 · Cited by 123 · cited 2×
“Nanoparticles have been used in MRI to visualise insulitis in individuals with recent-onset type 1 diabetes [116], and further studies of non-invasive radiological methods for insulitis”
BackgroundMethodWang, X., Jia, S., Geoffrey, R., Alemzadeh, R., Ghosh, S., & Hessner, M. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.3.1929 · Cited by 110 · cited 2×
“In the latter group, the gene expression signature preceded the appearance of autoantibodies [108, 109].”
BackgroundIA-2 autoantibodies predict impending Type I diabetes in siblings of patients
Decochez, K., Leeuw, I. D., Keymeulen, B., Mathieu, C., Rottiers, R., Weets, I., Vandemeulebroucke, E., Truyen, I., Kaufman, L., Schuit, F. C., et al. (2002) · Diabetologia · doi:10.1007/s00125-002-0949-8 · Cited by 108 · cited 5×
“GADA GAD autoantibodies IA-2A Insulinoma-associated antigen-2 autoantibodies IAA Insulin autoantibodies NGS Next-generation sequencing TEDDY The Environmental Determinants of Diabetes in the Young ZnT8A Zinc transporter 8 autoantibodies”
BackgroundInfluentialSerum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes
Zhang, Q., Fillmore, T., Schepmoes, A., Clauss, T. R., Gritsenko, M. A., Mueller, P. W., Rewers, M., Atkinson, M. A., Smith, R. D., & Metz, T. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111843 · Cited by 107 · cited 2×
“mune dysregulation characterise type 1 diabetes [110].”
BackgroundSosenko, J. M., Krischer, J. P., Palmer, J. P., Mahon, J., Cowie, C., Greenbaum, C. J., Cuthbertson, D., Lachin, J. M., Skyler, J. S., & the Diabetes Prevention Trial–Type 1 Study Group (2008) · Diabetes Care · doi:10.2337/dc07-1459 · Cited by 105
Yu, L., Boulware, D. C., Beam, C. A., Hutton, J. C., Wenzlau, J. M., Greenbaum, C. J., Bingley, P. J., Krischer, J. P., Sosenko, J. M., Skyler, J. S., et al. (2012) · Diabetes Care · doi:10.2337/dc11-2081 · Cited by 104
Novel Diabetes Autoantibodies and Prediction of Type 1 Diabetes
Wenzlau, J. M., & Hutton, J. C. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0405-9 · Cited by 103 · cited 1×
“number of further candidate autoantibodies have been identified [65].”
BackgroundReversion of β-Cell Autoimmunity Changes Risk of Type 1 Diabetes: TEDDY Study
Vehik, K., Lynch, K. F., Schatz, D. A., Akolkar, B., Hagopian, W., Rewers, M., She, J.-X., Simell, O., Toppari, J., Ziegler, A.-G., et al. (2016) · Diabetes Care · doi:10.2337/dc16-0181 · Cited by 103 · cited 1×
“Autoantibody titres do not always increase closer to the time of diabetes onset [72].”
BackgroundSelf-citationEstablished and emerging biomarkers for the prediction of type 1 diabetes: a systematic review
Watkins, R. A., Evans‐Molina, C., Blum, J. S., & DiMeglio, L. A. (2014) · Translational research · doi:10.1016/j.trsl.2014.02.004 · Cited by 101 · cited 1×
“Markers of T cell activation and beta cell destruction (such as beta cell-specific DNA, RNA and proteins) have been studied as indicators of increased diabetes risk and diabetes [115].”
BackgroundLamb, M. M., Miller, M., Seifert, J. A., Frederiksen, B., Kroehl, M., Rewers, M., & Norris, J. M. (2015) · Pediatric Diabetes · doi:10.1111/pedi.12115 · Cited by 97 · cited 1×
“Cow’s milk has been associated with both the development of beta cell autoimmunity and progression to type 1 diabetes in children with beta cell autoimmunity [56].”
BackgroundModels for Predicting Type 1 Diabetes in Siblings of Affected Children
Mrena, S., Virtanen, S. M., Laippala, P., Kulmala, P., Hannila, M.-L., Åkerblom, H. K., Knip, M., & the Childhood Diabetes in Finland Study Group (2006) · Diabetes Care · doi:10.2337/diacare.29.03.06.dc05-0774 · Cited by 97
Phases of type 1 diabetes in children and adolescents
Couper, J., Haller, M. J., Ziegler, A., Knip, M., Ludvigsson, J., & Craig, M. E. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12188 · Cited by 96 · cited 4×
“Autoantibodies Risk increases with number of autoantibody types Months to decades [50]”
BackgroundInfluentialDecreased Cord-Blood Phospholipids in Young Age–at–Onset Type 1 Diabetes
La Torre, D., Seppänen-Laakso, T., Larsson, H. E., Hyötyläinen, T., Ivarsson, S. A., Lernmark, Å., Orešič, M., & and the DiPiS Study Group (2013) · Diabetes · doi:10.2337/db13-0215 · Cited by 95 · cited 1×
“Cord blood phosphatidylcholines and phosphatidylethanolamines were significantly decreased in children diagnosed with type 1 diabetes before 4 years of age [112, 113].”
BackgroundSelf-citationGrijse, D. (2010) · doi:10.1007/s00125-009-1618-y · Cited by 94
Innate inflammation in type 1 diabetes
Cabrera, S. M., Henschel, A. M., & Hessner, M. J. (2015) · Translational research · doi:10.1016/j.trsl.2015.04.011 · Cited by 94 · cited 2×
“Mechanistically, it has been suggested that the microbiome affects innate immunity and may be linked to inflammatory serum signatures [87].”
BackgroundLamb, M. M., Frederiksen, B., Seifert, J. A., Kroehl, M., Rewers, M., & Norris, J. M. (2015) · Diabetologia · doi:10.1007/s00125-015-3657-x · Cited by 93 · cited 1×
“to clinical onset in children with beta cell autoantibodies, but not with the development of islet autoimmunity per se [61].”
BackgroundPrimary and secondary prevention of Type 1 diabetes
Skyler, J. S. (2013) · Diabetic Medicine · doi:10.1111/dme.12100 · Cited by 93 · cited 1×
“Large, prospective studies of environmental determinants of type 1 diabetes and efforts to translate their findings into preventative interventions are ongoing [62].”
BackgroundPreservation of β-cell function in autoantibody-positive youth with diabetes
Greenbaum, C. J., Anderson, A. M., Dolan, L. M., Mayer-Davis, E. J., Dabelea, D., Imperatore, G., Marcovina, S., Pihoker, C., & for the SEARCH Study Group (2009) · Diabetes Care · doi:10.2337/dc08-2326 · Cited by 90 · cited 1×
“In agreement with these findings, one-third of young people maintain C-peptide levels within the reference range 1 year after diagnosis [99].”
ResultZhao, Z., Sun, C., Wang, C., Li, P., Wang, W., Ye, J., Gu, X., Wang, X., Shen, S., Zhi, D., et al. (2014) · Acta Diabetologica · doi:10.1007/s00592-014-0590-2 · Cited by 88 · cited 1×
“In countries with a lower incidence of type 1 diabetes, the increase in incidence has been more marked [48] whereas in high-prevalence countries it may have decelerated [49].”
BackgroundAlternative Markers of Hyperglycemia and Risk of Diabetes
Juraschek, S. P., Steffes, M. W., Miller, E. R., & Selvin, E. (2012) · Diabetes Care · doi:10.2337/dc12-0787 · Cited by 88 · cited 1×
“All three markers are predictive of type 2 diabetes [96] but their utility for predicting type 1 diabetes has not been tested.”
BackgroundCord Serum Lipidome in Prediction of Islet Autoimmunity and Type 1 Diabetes
Orešič, M., Gopalacharyulu, P., Mykkänen, J., Lietzen, N., Mäkinen, M., Nygren, H., Simell, S., Simell, V., Hyöty, H., Veijola, R., et al. (2013) · Diabetes · doi:10.2337/db13-0159 · Cited by 88 · cited 2×
“Serum metabolome Reduced phosphatidylcholine From gestation [113]”
BackgroundAndersson, C., Larsson, K., Vaziri-Sani, F., Lynch, K., Carlsson, A., Cedervall, E., Jönsson, B., Neiderud, J., Månsson, M., Nilsson, A., et al. (2011) · Autoimmunity · doi:10.3109/08916934.2010.540604 · Cited by 86
Self-citationKnip, M., Kukko, M., Kulmala, P., Veijola, R., Simell, O., Åkerblom, H. K., & Ilonen, J. (2002) · American Journal of Medical Genetics · doi:10.1002/ajmg.10343 · Cited by 86
Stene, L. C., Barriga, K., Hoffman, M., Kean, J., Klingensmith, G., Norris, J. M., Erlich, H. A., Eisenbarth, G. S., & Rewers, M. (2006) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2006.00198.x · Cited by 84 · cited 1×
“Longitudinal measurements of random glucose values are less useful [95].”
BackgroundDelli, A. J., Vaziri-Sani, F., Lindblad, B., Elding-Larsson, H., Carlsson, A., Forsander, G., Ivarsson, S. A., Ludvigsson, J., Kockum, I., Marcus, C., et al. (2012) · Diabetes · doi:10.2337/db11-1659 · Cited by 80
Self-citationSosenko, J. M., Palmer, J. P., Rafkin-Mervis, L., Krischer, J. P., Cuthbertson, D., Matheson, D., & Skyler, J. S. (2008) · Diabetes Care · doi:10.2337/dc08-0935 · Cited by 78
Achenbach, P., Hummel, M., Thümer, L., Boerschmann, H., Höfelmann, D., & Ziegler, A. G. (2013) · Diabetologia · doi:10.1007/s00125-013-2896-y · Cited by 76 · cited 2×
“NonHLA SNPs may influence the rate of progression to clinical onset [66, 76].”
BackgroundResultBonifacio, E., Hummel, M., Walter, M., Schmid, S., & Ziegler, A.-G. (2004) · Diabetes Care · doi:10.2337/diacare.27.11.2695 · Cited by 76 · cited 1×
“Having multiple first-degree relatives with type 1 diabetes enhances the risk [7].”
BackgroundZhao, L. P., Alshiekh, S., Zhao, M., Carlsson, A., Elding Larsson, H., Forsander, G., Ivarsson, S. A., Ludvigsson, J., Kockum, I., Marcus, C., et al. (2016) · Diabetes · doi:10.2337/db15-1115 · Cited by 74 · cited 1×
“NGS typing of children with and without type 1 diabetes revealed that the association between type 1 diabetes and DRB1*03:01:01 was affected by DRB3*01:01:02 and DRB3*02:02:01 [30, 31].”
BackgroundSelf-citationPersistently autoantibody negative (PAN) type 1 diabetes mellitus in children
Hameed, S., Ellard, S., Woodhead, H. J., Neville, K. A., Walker, J. L., Craig, M. E., Armstrong, T., Yu, L., Eisenbarth, G. S., Hattersley, A. T., et al. (2011) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00681.x · Cited by 72 · cited 1×
“A small proportion of individuals with type 1 diabetes are negative for all the major islet autoantibodies [124].”
BackgroundCongenital rubella: citation virus or viral cause of type 1 diabetes?
Gale, E. A. M. (2008) · Diabetologia · doi:10.1007/s00125-008-1099-4 · Cited by 72
Effectiveness of Early Intensive Therapy on β-Cell Preservation in Type 1 Diabetes
Buckingham, B., Beck, R. W., Ruedy, K. J., Cheng, P., Kollman, C., Weinzimer, S. A., DiMeglio, L. A., Bremer, A. A., Slover, R., Tamborlane, W. V., et al. (2013) · Diabetes Care · doi:10.2337/dc13-1074 · Cited by 71 · cited 1×
“In contrast, a more recent study failed to demonstrate preserved beta cell function in newly diagnosed individuals receiving intensified anti-hyperglycaemic therapy compared with those receiving current standards of care [103].”
ResultOverview of the Type I Diabetes Genetics Consortium
Rich, S. S., Akolkar, B., Concannon, P., Erlich, H., Hilner, J. E., Julier, C., Morahan, G., Nerup, J., Nierras, C., Pociot, F., et al. (2009) · Genes & Immunity · doi:10.1038/gene.2009.84 · Cited by 69 · cited 1×
“Close to 60 genetic loci have been associated with susceptibility to type 1 diabetes [10].”
BackgroundDelli, A. J., Lindblad, B., Carlsson, A., Forsander, G., Ivarsson, S.-A., Ludvigsson, J., Marcus, C., Lernmark, Å., & for the Better Diabetes Diagnosis (BDD) Study Group (2010) · Pediatric Diabetes · doi:10.1111/j.1399-5448.2010.00637.x · Cited by 65 · cited 1×
“geographic variation in type 1 diabetes and migrants tend to establish an incidence of diabetes similar to that of the host population [45, 46].”
BackgroundSelf-citationJoint effects of HLA, INS, PTPN22 and CTLA4 genes on the risk of type 1 diabetes
Bjørnvold, M., Undlien, D. E., Joner, G., Dahl‐Jørgensen, K., Njølstad, P. R., Akselsen, H. E., Gervin, K., Rønningen, K. S., & Stene, L. C. (2008) · Diabetologia · doi:10.1007/s00125-008-0932-0 · Cited by 65 · cited 5×
“Most established susceptibility genes seem to act multiplicatively with other loci on the risk of disease, except for the joint effect of HLA and PTPN22 [44].”
BackgroundInfluentialAn integrated genotyping approach for HLA and other complex genetic systems
Nelson, W. C., Pyo, C.-W., Vogan, D., Wang, R., Pyon, Y.-S., Hennessey, C., Smith, A., Pereira, S., Ishitani, A., & Geraghty, D. E. (2015) · Human Immunology · doi:10.1016/j.humimm.2015.05.001 · Cited by 63 · cited 1×
“Using next-generation sequencing (NGS), an integrated genotyping system of exons 1–4 was developed to type all alleles of DRB1, DRB3, DRB4 and DRB5 [28, 29] (Fig.”
Methodfor the Swedish Better Diabetes Diagnosis Study Group, Carlsson, A., Kockum, I., Lindblad, B., Engleson, L., Nilsson, A., Forsander, G., Karlsson, A.-K., Kernell, A., Ludvigsson, J., et al. (2012) · International Journal of Obesity · doi:10.1038/ijo.2011.122 · Cited by 62 · cited 1×
“Details are available in electronic supplementary material Table 1 in [127]”
BackgroundSelf-citationType 1 Diabetes Manifested Solely by 2-h Oral Glucose Tolerance Test Criteria
Greenbaum, C. J., Cuthbertson, D., Krischer, J. P., & the Diabetes Prevention Trial of Type 1 Diabetes Study Group (2001) · Diabetes · doi:10.2337/diabetes.50.2.470 · Cited by 62
Epigenomics of autoimmune diseases
Gupta, B., & Hawkins, R. D. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.18 · Cited by 61 · cited 1×
“Only about half of monozygotic twins are concordant for type 1 diabetes [8], suggesting environmental and/or epigenetic influences [9].”
BackgroundConfirmation of novel type 1 diabetes risk loci in families
the Type 1 Diabetes Genetics Consortium, Cooper, J. D., Howson, J. M. M., Smyth, D., Walker, N. M., Stevens, H., Yang, J. H. M., She, J.-X., Eisenbarth, G. S., Rewers, M., et al. (2012) · Diabetologia · doi:10.1007/s00125-012-2450-3 · Cited by 60 · cited 1×
“Variants of some 50 genes have been identified as affecting the risk for type 1 diabetes [121].”
BackgroundSosenko, J. M., Skyler, J. S., Herold, K. C., Palmer, J. P., & Groups, T. T. 1. D. T. A. D. P. T. 1. S. (2012) · Diabetes · doi:10.2337/db11-1660 · Cited by 60
Protection against or triggering of Type 1 diabetes? Different roles for viral infections
Boettler, T., & von Herrath, M. (2010) · Expert Review of Clinical Immunology · doi:10.1586/eci.10.91 · Cited by 54 · cited 1×
“Proposed mechanisms include T cell crossreactivity between viruses and islet autoantigens or exposure of beta cell autoantigens to nearby inflammation [51].”
BackgroundDistinct Roles of β-Cell Mass and Function During Type 1 Diabetes Onset and Remission
Chmelova, H., Cohrs, C. M., Chouinard, J. A., Petzold, C., Kühn, M., Chen, C., Roeder, I., Kretschmer, K., & Speier, S. (2015) · Diabetes · doi:10.2337/db14-1055 · Cited by 53 · cited 1×
“It is believed that the treatment of hyperglycaemia reverses beta cell exhaustion [101].”
BackgroundBelgian Diabetes Registry, Decochez, K., Truyen, I., der Auwera, B. J. R. V., Weets, I., Vandemeulebroucke, E., Leeuw, I. H. D., Keymeulen, B., Mathieu, C., Rottiers, R., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-1702-x · Cited by 52 · cited 1×
“A 10 year follow-up of children with multiple islet autoantibodies showed that the HLA-DR3-DQ2/DR4-DQ8 genotype had a greater risk for diabetes than children with other HLA genotypes [75], yet smaller studies have failed to show that HLA genotype influences the rate of progression [76].”
ResultIncreased Complement Activation in Human Type 1 Diabetes Pancreata
Rowe, P. A., Wasserfall, C. H., Croker, B. P., Campbell‐Thompson, M., Pugliese, A., Atkinson, M. A., & Schatz, D. (2013) · Diabetes Care · doi:10.2337/dc13-0203 · Cited by 52 · cited 1×
“uals with type 1 diabetes, 7% of autoantibody-positive nondiabetic individuals and 2% of autoantibody-negative non-diabetic individuals [88].”
BackgroundGorus, F. K., Balti, E. V., Vermeulen, I., Demeester, S., Van Dalem, A., Costa, O., Dorchy, H., Tenoutasse, S., Mouraux, T., De Block, C., et al. (2012) · Clinical and Experimental Immunology · doi:10.1111/j.1365-2249.2012.04675.x · Cited by 51 · cited 5×
“GADA GAD autoantibodies IA-2A Insulinoma-associated antigen-2 autoantibodies IAA Insulin autoantibodies NGS Next-generation sequencing TEDDY The Environmental Determinants of Diabetes in the Young ZnT8A Zinc transporter 8 autoantibodies”
BackgroundInfluentialNext Generation Sequencing Reveals the Association of DRB3*02:02 With Type 1 Diabetes
Erlich, H. A., Valdes, A. M., McDevitt, S. L., Simen, B. B., Blake, L. A., McGowan, K. R., Todd, J. A., Rich, S. S., Noble, J. A., & for the Type 1 Diabetes Genetics Consortium (T1DGC) (2013) · Diabetes · doi:10.2337/db12-1387 · Cited by 51
Performance of HbA1c as an Early Diagnostic Indicator of Type 1 Diabetes in Children and Youth
Vehik, K., Cuthbertson, D., Boulware, D., Beam, C. A., Rodriguez, H., Legault, L., Hyytinen, M., Rewers, M. J., Schatz, D. A., Krischer, J. P., et al. (2012) · Diabetes Care · doi:10.2337/dc12-0111 · Cited by 48 · cited 2×
“Increase in HbA1c may be used as a marker of high specificity but poor sensitivity for clinical onset [94].”
BackgroundHirai, H., Miura, J., Hu, Y., Larsson, H. E., Larsson, K., Lernmark, Å., Ivarsson, S. A., Wu, T., Kingman, A., Tzioufas, A. G., et al. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.01.018 · Cited by 47 · cited 2×
“Minor autoantibodies Found in fewer than 30% of individuals Unknown [123]”
BackgroundSelf-citationEndesfelder, D., Hagen, M., Winkler, C., Haupt, F., Zillmer, S., Knopff, A., Bonifacio, E. E., Ziegler, A., zu Castell, W., & Achenbach, P. (2016) · Diabetologia · doi:10.1007/s00125-016-4050-0 · Cited by 45
Andersson, C., Kolmodin, M., Ivarsson, S.-A., Carlsson, A., Forsander, G., Lindblad, B., Ludvigsson, J., Kockum, I., Marcus, C., Samuelsson, U., et al. (2014) · Pediatric Diabetes · doi:10.1111/pedi.12093 · Cited by 44 · cited 1×
“The presence of multiple autoantibodies greatly increases the probability for type 1 diabetes—70% of diabetic individuals have three or four autoantibodies, while only 10% have a single autoantibody [63, 64].”
BackgroundSelf-citationWiberg, A., Granstam, A., Ingvast, S., Härkönen, T., Knip, M., Korsgren, O., & Skog, O. (2015) · Clinical and Experimental Immunology · doi:10.1111/cei.12698 · Cited by 43 · cited 1×
“The limited human histological evidence available suggests that persistent inflammation of pancreatic islets (insulitis) is present in only a small proportion of nondiabetic, autoantibody-positive individuals and that insulitis emerges closer to the clinical onset [77, 78].”
BackgroundSmith, A. G., Pyo, C., Nelson, W. C., Gow, E., Wang, R., Shěn, S., Sprague, M., Pereira, S. E., Geraghty, D. E., & Hansen, J. A. (2014) · Human Immunology · doi:10.1016/j.humimm.2014.08.206 · Cited by 42 · cited 1×
“Using next-generation sequencing (NGS), an integrated genotyping system of exons 1–4 was developed to type all alleles of DRB1, DRB3, DRB4 and DRB5 [28, 29] (Fig.”
MethodTörn, C., Liu, X., Hagopian, W., Lernmark, Å., Simell, O., Rewers, M., Ziegler, A., Schatz, D., Akolkar, B., Önengüt-Gümüşcü, S., et al. (2016) · Scientific Reports · doi:10.1038/srep27887 · Cited by 41 · cited 3×
“The relevance of the complement system to type 1 diabetes has been suggested by the association with HLA class III SNPs [35, 36].”
BackgroundSelf-citationPredictors of slow progression to diabetes in children with multiple islet autoantibodies
Steck, A. K., Dong, F., Waugh, K., Frohnert, B. I., Yu, L., Norris, J. M., & Rewers, M. J. (2016) · Journal of Autoimmunity · doi:10.1016/j.jaut.2016.05.010 · Cited by 40 · cited 2×
“single tomultiple beta cell autoantibodies and lower IAA titres may predict a delayed clinical onset [66, 67].”
BackgroundJin, Y., Sharma, A., Bai, S., Davis, C., Liu, H., Hopkins, D., Barriga, K., Rewers, M., & She, J.-X. (2014) · Diabetes · doi:10.2337/db13-1716 · Cited by 38 · cited 1×
“Transcriptomics (study of patterns of gene expression) has shown promise for risk stratification of autoantibody-positive individuals [107].”
BackgroundXu, P., Beam, C. A., Cuthbertson, D., Sosenko, J. M., Skyler, J. S., Krischer, J. P., & the DPT-1 Study Group (2012) · Diabetes Care · doi:10.2337/dc12-0183 · Cited by 37
Sørensen, I. M., Joner, G., Jenum, P. A., Eskild, A., & Stene, L. C. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2293 · Cited by 32 · cited 1×
“prospective birth cohort study found no association between maternal long-chain n-3 fatty acid levels during pregnancy and the development of type 1 diabetes in offspring [58].”
BackgroundCollection Protocol for Human Pancreas
Campbell‐Thompson, M., Montgomery, E. L., Foss, R. M., Kolheffer, K. M., Phipps, G., Schneider, L. C., & Atkinson, M. A. (2012) · Journal of Visualized Experiments · doi:10.3791/4039 · Cited by 32
Multiple autoantibodies as predictors of Type 1 diabetes in a general population
Maclaren, N. K., Notkins, A. L., Krischer, J. P., Lan, M. S., Schatz, D., & Malone, J. I. (2003) · Diabetologia · doi:10.1007/s00125-003-1123-7 · Cited by 31
The Development, Validation, and Utility of the Diabetes Prevention Trial-Type 1 Risk Score (DPTRS)
Groups, T. D. T. 1. T. A. D. P. T.-T. 1. S., Sosenko, J. M., Skyler, J. S., & Palmer, J. P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0626-1 · Cited by 31
Seroconversion to Islet Autoantibodies After Enterovirus Infection in Early Pregnancy
Lindehammer, S. R., Honkanen, H., Nix, W. A., Oikarinen, M., Lynch, K. F., Jönsson, I., Maršál, K., Oberste, S. M., Hyöty, H., & Lernmark, Å. (2012) · Viral Immunology · doi:10.1089/vim.2012.0022 · Cited by 29 · cited 1×
“Coxsackie infection during pregnancy may induce beta cell autoimmunity in the mother [53] and may increase the risk for type 1 diabetes in the offspring [54, 55].”
BackgroundSelf-citationValdes, A. M., Thomson, G., Graham, J., Zarghami, M., McNeney, B., Kockum, I. S., Smith, A. G., Lathrop, M. G., Steenkiste, A. R., Dorman, J. S., et al. (2005) · Diabetologia · doi:10.1007/s00125-005-0011-8 · Cited by 27 · cited 1×
“Some MHC class I variants affect the risk of type 1 diabetes, even after adjusting for linkage disequilibrium toMHC class II haplotypes [32].”
BackgroundSelf-citationNon-HLA type 1 diabetes genes modulate disease risk together with HLA-DQ and islet autoantibodies
Maziarz, M., Hagopian, W., Palmer, J. P., Sanjeevi, C. B., Kockum, I. S., Breslow, N. E., Lernmark, Å., Graham, J., MacNeney, B., Arnqvist, H. J., et al. (2015) · Genes and Immunity · doi:10.1038/gene.2015.43 · Cited by 23 · cited 14×
“Non-HLA genotype About 50 candidate genes From gestation [37]”
BackgroundInfluentialSelf-citationLaine, A., Holmberg, H., Nilsson, A., Örtqvist, E., Kiviniemi, M., Vaarala, O., Åkerblom, H. K., Simell, O., Knip, M., Ludvigsson, J., et al. (2007) · Disease Markers · doi:10.1155/2007/574363 · Cited by 18 · cited 1×
“HLA genotypes in the high-risk Scandinavian countries are similar but genetic differences between the countries prevail [27].”
BackgroundSelf-citationDiabetes Complications in Childhood Diabetes: New Biomarkers and Technologies
Bjornstad, P., & Maahs, D. M. (2015) · Current Pediatrics Reports · doi:10.1007/s40124-015-0081-0 · Cited by 16 · cited 1×
“In addition to biomarkers for the prediction of type 1 diabetes itself, predictors of angiopathic and neuropathic complications of the disease are being investigated [106].”
BackgroundValdés, A., Thomson, G., & Barcellos, L. (2010) · Genes and Immunity · doi:10.1038/gene.2009.104 · Cited by 12 · cited 3×
“The relevance of the complement system to type 1 diabetes has been suggested by the association with HLA class III SNPs [35, 36].”
BackgroundResult
Cited by
Lowe, W. L., Scholtens, D. M., Lowe, L. P., Kuang, A., Nodzenski, M., Talbot, O., Catalano, P. M., Linder, B., Brickman, W. J., Clayton, P., et al. (2018) · JAMA · doi:10.1001/jama.2018.11628 · Cited by 591
“Therewere4motherswithdiabeteswhowereexcludedbased onantibodies consistentwith type 1diabetes.(7)Prediabeteswas”
Chen, B., Yu, P., Chan, W. N., Xie, F., Zhang, Y., Liang, L., Leung, K. T., Lo, K. W., Yu, J., Tse, G. M. K., et al. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01679-y · Cited by 420
“228 231 Furthermore, ZnT8 autoantibodies are detected in approximately 60 – 80% of new cases that are clinically con fi rmed as being affected by type 1 diabetes within the patient population.”
BackgroundTargeted Elimination of Senescent Beta Cells Prevents Type 1 Diabetes
Thompson, P. J., Shah, A., Ntranos, V., Van Gool, F., Atkinson, M., & Bhushan, A. (2019) · Cell Metabolism · doi:10.1016/j.cmet.2019.01.021 · Cited by 353
Subtypes of Type 2 Diabetes Determined From Clinical Parameters
Ahlqvist, E., Prasad, R. B., & Groop, L. (2020) · Diabetes · doi:10.2337/dbi20-0001 · Cited by 229
“Type 1 diabetes (T1D) and latent autoimmune diabetes of the adult (LADA) both result from autoimmune destruction of b-cells, often, but not always, reflected by presence of pancreatic autoantibodies in the blood that can be used as a diagnostic marker (3).”
BackgroundDiagnosis and treatment of type 1 diabetes at the dawn of the personalized medicine era
Akil, A. A.-S., Yassin, E., Al-Maraghi, A., Aliyev, E., Al-Malki, K., & Fakhro, K. A. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02778-6 · Cited by 168
Metadata
- Authors
- Regnell, S. E., & Lernmark, Å.
- Affiliations
- Lund University (SE)
- Corresponding author
- Lernmark, Åke
- Venue
- Diabetologia
- Published
- 2017-05-26
- Volume
- 60
- Issue
- 8
- Pages
- 1370-1381
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- PMC
- PMC5491594
- OpenAlex
- W2620432821
- Cited by
- 195
- References
- 127
- Citations by year
- 2026: 8 · 2025: 12 · 2024: 16 · 2023: 26 · 2022: 30 · 2021: 41 · 2020: 20 · 2019: 20 · 2018: 17 · 2017: 5
- FWCI
- 2.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Locations
- Diabetologia (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Lund University
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- type 1 diabetes, early prediction, insulin autoantibodies, glutamic acid decarboxylase antibodies, HLA-DQ8, HLA-DQ2, HLA class II, beta-cell mass loss, islet infiltration, mononuclear cell infiltration, type 1 diabetes prevention, genetic susceptibility
- MeSH terms
- Autoantibodies, Child, Diabetes Mellitus, Type 1, Female, Glutamate Decarboxylase, Humans, Insulin Antibodies, Male
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.